Application of combined antigen for African lymphocytoma virus to test serum reactions of nasopharyngeal cancer patient before and after treatment

Application Number: 00109576
Application Date: 2000.07.05
Publication Number: 1331415
Publication Date: 2002.01.16
Priority Information:
International: C07K14/05;G01N33/536;G01N33/543;G01N33/569
Applicant(s) Name: Qinli Biologic Science and Technology Co Ltd
Inventor(s) Name: Zhou Kuanji
Patent Agency Code: 11021
Patent Agent: zhu liguang
Abstract A method for estimating the curative effect of nasopharyngeal cancer patient by using the combined antigen of African lymphocytoma virus (EB), especially the DBP, EA-D, EBNA-1, EDP, TK and ZEBRA antigens is disclosed, which features use of immunologic assay be duplicating the said 6 antigens.